Novavax eyes bringing its COVID-19 vaccine to the U.S. market
$1
Beer, doughnuts, and a $1 million lottery: How vaccine incentives can help the U.S. reach herd immunity
Should my child get the COVID-19 vaccine? 7 questions answered
No, vaccine side effects don’t tell you how well your immune system will protect you from COVID-19
Twitter is adding a COVID-19 vaccine fact box to user timelines
What to know if you just got the Johnson & Johnson vaccine
The FDA tells states to cease use of the Johnson & Johnson vaccine over blood clot fears
Uber, PayPal and Walgreens set up a Vaccine Access Fund
We’re not getting a national vaccine passport. Here’s why it never stood a chance
Your COVID-19 vaccine could be in the back of a van
New York rolls out first digital COVID-19 vaccine passports in the US
When can kids get the COVID-19 vaccine? A pediatrician answers 5 key questions
Report links most vaccine misinformation online to just 12 people
3 ways employers can help fight vaccine skepticism
How to build an equitable vaccine passport that respects people’s privacy
Inside the ad industry’s moonshot: Pitching you to get the COVID-19 vaccine
Vaccine passports are coming. Here’s why they’re controversial
Pfizer’s CEO reflects on a year of discovery and what he thinks critics get wrong about vaccine pricing
The pros and cons of vaccine passports
IBM Watson boosts vaccine campaign, Pinterest climbing: Friday’s daily brief
This is how the Johnson & Johnson vaccine is different from Pfizer and Moderna’s shots
5 strikes and you’re out. Twitter’s new policy to rid the platform of vaccine misinformation
7 tangible ways to make vaccine websites more accessible
National Geographic’s new documentary tells the inside story of Pfizer’s COVID-19 vaccine
Johnson & Johnson’s 1-shot COVID vaccine gets initial OK from the FDA